Apart from 🥚 dysfunction, cirrhotic pts have 🩸dynamic alterations that make them prone to AKI:
❤️ ⬆️ portal pressure 2/2 structural (fibrosis, nodule formation, thrombosis) & dynamic (⭐ cells responsive to vasoactive agents)
❤️ ⬇️ SVR & EAV
❤️ ⬆️ CO
❤️ ⬆️ RAAS, ADH & SNS
❤️ ⬆️ portal pressure 2/2 structural (fibrosis, nodule formation, thrombosis) & dynamic (⭐ cells responsive to vasoactive agents)
❤️ ⬇️ SVR & EAV
❤️ ⬆️ CO
❤️ ⬆️ RAAS, ADH & SNS
Portal ⬆️tension causes splanchnic vasodilation, but... what are the mediators involved here?
AKI in cirrhotic pts requires special consideration because of the broad differential and the risk of progression to HRS. For that matter, I find this algorythm by @VelezNephHepato et al. a great tool:
Along the same line of thought, not every AKI in cirrhotic pts is going to be fluid responsive, and for that matter, this clinical case and analysis by my good friend @ArgaizR settles the question nicely!
criticalcarenow.com
criticalcarenow.com
Wrapping up this brief rant on 🥚 magical properties:
🥚 Has 🚫inflammatory, 🚫oxidative & immunonodulatory effects
🥚 dysfunctional as severity of cirrhosis⬆️
🥚 Useful in LVP, SBP, AKI, HRS & more!
🥚 Not every AKI responds to 💧, 👀JVP (as per @AndreMansoor) & POCUS useful
🥚 Has 🚫inflammatory, 🚫oxidative & immunonodulatory effects
🥚 dysfunctional as severity of cirrhosis⬆️
🥚 Useful in LVP, SBP, AKI, HRS & more!
🥚 Not every AKI responds to 💧, 👀JVP (as per @AndreMansoor) & POCUS useful
Hope you enjoyed this 🧵!
Sources (PMID or DOI):
3360270
19642174
31723234
30213943
12297842
10432325
32102926
10.1016/j.mam.2007.09.010
Sources (PMID or DOI):
3360270
19642174
31723234
30213943
12297842
10432325
32102926
10.1016/j.mam.2007.09.010
Loading suggestions...